Go Pro
NASDAQ:UTMD

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$71.81 -0.97 (-1.33%)
Closing price 04:00 PM Eastern
Extended Trading
$71.96 +0.14 (+0.20%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$71.50
$74.40
50-Day Range
$63.34
$73.97
52-Week Range
$53.66
$75.75
Volume
22,799 shs
Average Volume
14,560 shs
Market Capitalization
$228.36 million
P/E Ratio
21.25
Dividend Yield
1.73%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 19% of companies evaluated by MarketBeat, and ranked 760th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 21.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 21.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.35.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    4.48% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 15.27, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 16.03%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.70%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 36.69%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • MarketBeat Follows

    2 people have added Utah Medical Products to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

Iran just proved America's energy strategy is broken
When the U.S.-Iran deal allowed Iranian oil to flow again, energy stocks dropped 1.7% almost instantly - proving how exposed American energy policy remains to foreign supply decisions. But beneath U.S. soil sits an energy source estimated at 50,000 times the size of all global oil and gas reserves combined. It can't be sanctioned, embargoed, or shut off. Last year, a drilling crew hit targets 12 years ahead of schedule. Google signed a 15-year deal. Gates wrote the check. One company sits at the center, with August 18th as a key date to watch.tc pixel
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the start of the year. Since then, UTMD shares have increased by 28.3% and is now trading at $71.81.

Utah Medical Products, Inc. (NASDAQ:UTMD) posted its quarterly earnings results on Thursday, April, 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. The medical instruments supplier had revenue of $8.72 million for the quarter. Utah Medical Products had a net margin of 28.90% and a trailing twelve-month return on equity of 9.13%.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

Last Earnings
4/23/2026
Record date for 7/3 Dividend
6/17/2026
Ex-Dividend for 7/3 Dividend
6/17/2026
Dividend Payable
7/03/2026
Today
7/06/2026
Next Earnings (Estimated)
7/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
180
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.38
Trailing P/E Ratio
21.25
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
28.90%
Pretax Margin
35.79%
Return on Equity
9.13%
Return on Assets
8.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
28.64
Quick Ratio
26.15

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
5.93
Cash Flow
$4.40 per share
Price / Cash Flow
16.31
Book Value
$37.23 per share
Price / Book
1.93

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$228.36 million
Optionable
Not Optionable
Beta
0.36

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 7/6/2026 by MarketBeat.com Staff.
From Our Partners